A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2006
11/23/2006	WO2006124662A1 Il-12 modulatory compounds
11/23/2006	WO2006124462A2 Compounds and compositions as protein kinase inhibitors
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123618A1 Oxidative stress inhibitor
11/23/2006	WO2006123550A1 Prophylactic or therapeutic agent for inflammatory disease
11/23/2006	WO2006123247A2 Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
11/23/2006	WO2006122806A2 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors
11/23/2006	WO2006122800A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
11/23/2006	WO2006122799A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
11/23/2006	WO2006122772A1 Salts of substituted allophanates and their use in drugs
11/23/2006	WO2006122771A2 Substituted benzo-condensed cyclohexanone derivatives and the use thereof for medicament production
11/23/2006	WO2006122770A1 Substituted spiro compounds and their use for producing pain-relief medicaments
11/23/2006	WO2006122769A2 Substituted spiro compounds and their use for producing pain-relief drugs
11/23/2006	WO2006122723A1 Method for the prevention and/or treatment of autoimmune disease or allogeneic transplant rejections
11/23/2006	WO2006122680A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
11/23/2006	WO2006122512A1 Fusion proteins comprising protein transduction domain, auxiliary protein and bioactive protein, their production and uses
11/23/2006	WO2006122403A1 Quinoline derivatives as ep4 antagonists
11/23/2006	WO2006122363A1 Therapeutic agents and targets
11/23/2006	WO2006110884A3 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
11/23/2006	WO2006106437A3 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
11/23/2006	WO2006098918A3 Substituted gamma lactams as therapeutic agents
11/23/2006	WO2006094828A3 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/23/2006	WO2006088833A3 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
11/23/2006	WO2005033911A3 Image analysis method and apparatus in a network that is structured with multiple layers and differentially weighted neurons
11/23/2006	US20060264638 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264443 Treatment of rheumatoid arthritis
11/23/2006	US20060264441 N-[(1-azabicyclo[2.2.2]oct-2-yl)arylmethyl]-benzamide derivatives; psychological, behavioral, eating, sexual, sleep, nervous system, and/or neurodegenerative disorders; drug abuse, alcoholism, schizophrenia, psychoses, Parkinson*s disease, epilepsy; analgesics, antidepressants, anxiolytic agents
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264393 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
11/23/2006	US20060264378 Cxcr4 antagonist and use thereof
11/23/2006	US20060264354 Cop 1 for treatment of inflammatory bowel diseases
11/23/2006	US20060263881 Methods of expanding and selecting disease associated T-Cells
11/23/2006	US20060263447 Treating pulmonary disorders with gaseous agent causing repletion of GSNO
11/23/2006	US20060263430 instrument for inducing cytokine and method of inducing cytokine
11/23/2006	US20060263422 Pharmaceutical composition containing decoy and use of the same
11/23/2006	CA2608773A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
11/23/2006	CA2608770A1 Improved nanobodies against tumor necrosis factor-alpha
11/23/2006	CA2608540A1 3-cyanoquinoline inhibitors of tpl2 kinase and methods of making and using the same
11/23/2006	CA2608498A1 Anti-gm-csf antibodies and uses therefor
11/23/2006	CA2608496A1 Imidazoquinolines as lipid kinase inhibitors
11/23/2006	CA2608447A1 Oxidative stress inhibitor
11/23/2006	CA2608386A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
11/23/2006	CA2608385A1 Substituted spiro compounds and their use for producing drugs
11/23/2006	CA2608309A1 Substituted spiro compounds and their use for producing pain-relief medicaments
11/23/2006	CA2608214A1 Quinoline derivatives as ep4 antagonists
11/23/2006	CA2608010A1 Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
11/23/2006	CA2607299A1 Compounds and compositions as protein kinase inhibitors
11/23/2006	CA2606867A1 Methods of using pnkp30, a member of the b7 family, to modulate the immune system
11/23/2006	CA2606769A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases associated with toll-like receptors
11/23/2006	CA2604562A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1724271A1 Preventive and/or therapeutic agent for neutrophilic inflammation disease
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1724263A1 Basic amine compound and use thereof
11/22/2006	EP1724258A1 Heteroarylphenylurea derivative
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1723131A1 Crystalline polymorphs of a cxc-chemokine receptor ligand
11/22/2006	EP1722796A2 Tetracyclic lactam derivatives and uses thereof
11/22/2006	EP1722771A1 Compositions and methods for preventing or treating an inflammatory response
11/22/2006	EP1722764A1 Methods for relief of pain
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1458721B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/22/2006	EP1432402B1 Compositions for delivery of drug combinations
11/22/2006	EP1427717B1 Bioprecursors for percutaneous application
11/22/2006	EP1420778B1 Use of mek inhibitors for treating virus induced hemorrhagic shock or fever
11/22/2006	EP1370575B1 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1342472B1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylacetic acid
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1315482B1 Water-dispersible encapsulated sterols
11/22/2006	EP1312364B1 Gatifloxacin as cytokine production inhibitor
11/22/2006	EP1299081B1 Use of oligosaccharides to stimulate beta-endorphin production
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	EP1080070B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP1000158B1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
11/22/2006	EP0942925B1 Inhibitors of interleukin-1 beta converting enzyme
11/22/2006	EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase
11/22/2006	CN1867577A Estratriene derivatives
11/22/2006	CN1867555A Rearranged pentanols, a process for their production and their use as anti-inflammatory agents
11/22/2006	CN1867551A Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists
11/22/2006	CN1867352A Therapeutic uses of chemokine variants
11/22/2006	CN1867339A Novel use of cannabinoid receptor agonist
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1865249A Oxazole analog derivative and its preparation method and its anti-inflammatory and analgesic uses
11/22/2006	CN1864743A Methods for the treatment of insulin resistance and disease states characterized by insulin resistance
11/22/2006	CN1864740A A Chinese medicinal composition for clearing heat and expelling toxin and preparation method thereof
11/22/2006	CN1864723A Ointment for treating soft tissue strain and contusion
11/22/2006	CN1864722A A pharmaceutical composition for treating muscles and bones pain and lumbar intervertebral disc protrusion

1 ... 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 ... 1272